
Glipwohn M 5mg/500mg Tablet
Marketer
Riyadh Pharmaceutical
Salt Composition
Glipizide (5mg) + Metformin (500mg)
Overview Glipwohn M 5mg/500mg Tablet
Diabetic patients using the medication Glyburide/Metformin 5mg/500mg tablets should be aware that it's an anti-diabetic combination drug for type 2 diabetes management in adults. This medication regulates blood glucose levels, and optimal effectiveness requires consistent daily dosing at the same time, ideally with meals. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Discontinuing this medication without medical supervision is strongly discouraged, as it may lead to elevated blood sugar, potentially causing kidney problems, vision loss, nerve damage, and limb complications. Remember, this medication is only one component of a comprehensive diabetes management plan, which also includes a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headaches, and tremors—and how to treat them using a fast-acting sugar source (e.g., juice, candy). Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling (edema), blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Individuals with a history of heart disease should inform their doctor before starting this treatment. Pregnant or breastfeeding women should consult their physician. Regular blood glucose monitoring, along with blood tests to check blood counts and liver function, are essential during treatment.
Primary Ingredients of Glipwohn M 5mg/500mg Tablet
No text provided to rephrase.
Major Benefits of Glipwohn M 5mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glipwohn M 5mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Glipwohn M 5mg/500mg Tablet:
- Headache
- Diarrhea
- Hypoglycemia (low blood glucose level)
How to use Glipwohn M 5mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glipwohn M 5mg/500mg tablets should be administered with a meal.
How Glipwohn M 5mg/500mg Tablet works:
Glipizide, a sulfonylurea drug, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glipwohn M 5mg/500mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Glipwohn M 5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Glipwohn M 5mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary clinical evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Glipwohn M 5mg/500mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glipwohn M 5mg/500mg Tablets. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Caution is advised when prescribing Glipwohn M 5mg/500mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended. For patients exhibiting mild to moderate liver disease, initiation should involve a low Glipwohn M 5mg/500mg tablet dosage; however, its use is contraindicated in cases of severe liver dysfunction.
What if you forget to take Glipwohn M 5mg/500mg Tablet :
Should you forget a Glipwohn M 5mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glipwohn M 5mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
